The first episode of CancerNetwork's podcast Oncology Peer Review On-The-Go explores disparities in cancer care treatment among minorities and the significance of a representative sample in clinical trials.
CancerNetwork talks with Dr. Christopher Flowers of the MD Anderson Cancer Center regarding "Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical Trials" from the journal ONCOLOGY.
Then, Dr. Julie Vose of the University of Nebraska Medical Center gives her perspective on the factors leading to cancer care disparities and the significance of representative enrollment in clinical trials.
Similar Splenic, Symptom Responses Are Reported With Ruxolitinib Combos in Myelofibrosis With Anemia
June 13th 2025Results of a post hoc analysis found spleen and symptom response rates to be comparable with ESAs or danazol in combination with ruxolitinib for patients with myelofibrosis who have anemia.